peoplePerson
Won Ki Kang
A senior gastric cancer oncologist whose adjuvant and perioperative trials in Korea helped define post-gastrectomy chemotherapy.
Won Ki Kang has led Korean multicentre trials in gastric cancer including the ARTIST studies of adjuvant chemoradiation and has been an investigator on first-line immunotherapy and HER2 trials.
Role
Professor of Medical Oncology; gastrointestinal oncology
Institution
Specialisms
Gastric cancerAdjuvant chemotherapyClinical trials
| Title | Journal | Year |
|---|---|---|
| Phase III trial of adjuvant capecitabine/cisplatin with or without radiotherapy in D2-resected gastric cancer (ARTIST) | Journal of Clinical Oncology | 2012 |